John A. Lewicki, EVP & Chief Scientific Officer at OncoMed Pharmaceuticals Inc (OMED), sold 17,000 shares at $25.29 ($430K) on 2015-04-02, disclosed to the SEC on 2015-04-03.
Scheduled sale ($430k) by EVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.19 | 8,500 | $214K | 49.8% |
| 2 | $25.29 | 6,940 | $176K | 40.8% |
| 3 | $25.70 | 1,560 | $40K | 9.3% |
| Total | $25.28 avg | 17,000 | $430K | 100% |
| Filing → |
| OMED | SELL | 2018-10-11 | $2K | — | Filing → |
| OMED | SELL | 2018-10-10 | $5K | — | Filing → |
| OMED | SELL | 2018-04-26 | $12K | — | Filing → |